|
Aug 13
|
The Good Rice Alliance Awarded 'Ae', a top quartile ex ante rating, by BeZero Carbon
|
|
Aug 13
|
Vividion Therapeutics Appoints Sam Whiting, M.D., Ph.D., as Chief Medical Officer
|
|
Aug 12
|
Are Investors Undervaluing Bayer (BAYRY) Right Now?
|
|
Aug 12
|
New .med Domain Names Surpass 40,000 Pre-Orders in July
|
|
Aug 12
|
DNLI Tops on Q2 Earnings, Expects Decree on Hunter Syndrome Drug in '26
|
|
Aug 12
|
Bayer and Kumquat Biosciences enter global exclusive license and collaboration in precision oncology
|
|
Aug 12
|
Quantified Named to 2025 Inc. 5000, One of the 50 Fastest-Growing AI Firms in the U.S.
|
|
Aug 12
|
Bayer, Kumquat Biosciences Team Up on New Potential Cancer Drug
|
|
Aug 11
|
Non-metastatic Prostate Cancer Market Analysis and Forecast, 2023-2035 | J&J, Astellas, Bristol-Myers Squibb, Pfizer, Merck, Bayer, Sanofi, Clovis, AstraZeneca, AbbVie, and Boehringer Lead Innovations
|
|
Aug 7
|
Viatris Stock Rises as Q2 Earnings & Revenues Beat Estimates
|
|
Aug 7
|
Bayer Second Quarter 2025 Earnings: EPS Misses Expectations
|
|
Aug 7
|
K36 Therapeutics Receives FDA Clearance of Investigational New Drug (IND) Application for KTX-2001 in Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Announces Clinical Trial Collaboration with Bayer for Supply of Darolutamide
|
|
Aug 7
|
Why Liverpool’s Wirtz is causing concern at big pharma company Bayer
|
|
Aug 7
|
Clinical trial supply chains in the US navigate pharma tariffs
|
|
Aug 6
|
Basic Materials Roundup: Market Talk
|
|
Aug 6
|
RXRX Q2 Loss Wider Than Expected, Revenues Rise Y/Y, Stock Down
|
|
Aug 6
|
Bayer Beats on Q2 Earnings and Sales, Raises '25 Adjusted Sales View
|
|
Aug 6
|
Is Amarin (AMRN) Outperforming Other Medical Stocks This Year?
|
|
Aug 6
|
[Latest] Global Lawn and Garden Consumables Market Size/Share Worth USD 38 Billion by 2034 at a 4.36% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
|
|
Aug 6
|
India's Bayer CropScience posts higher quarterly profit on strong herbicide, corn seed demand
|